Why GMO Crops (Probably) Can't Compete for This $22 Billion Ingredient Opportunity
You may not realize it yet, but the bioeconomy is at a historic crossroads. The world's largest agricultural companies are on the cusp of developing genetically engineered crops capable of producing novel ingredients for animal feeds, which are currently sourced from supply-constrained production systems.
We have 10,000 years of experience growing crops, supply chains are firmly in place, and there are multiple market needs. There's a $22 billion-per-year bounty up for grabs -- and it figures to be a layup for the industry.
That's what looking backward at the technology landscape would predict, anyway, but new technologies may keep GMO crops from running away with the multibillion-dollar market opportunity. What happens in the next few years may force investors to readjust their long-term outlook for grain logistics experts such as Archer Daniels Midland (NYSE: ADM) and crop technology specialists such as Monsanto (NYSE: MON).
Source: Fool.com
Archer-Daniels-Midland Co. Aktie
Die Archer-Daniels-Midland Co. Aktie zieht etwas Aufmerksamkeit auf sich: Mehr Buy- als Sell-Einschätzungen.
Das von der Community festgelegte Kursziel für Archer-Daniels-Midland Co. von 78 € impliziert eine deutliche Steigerung gegenüber dem aktuellen Kurs von 58.93 €.
